Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
28%
OVERLAP
BY WEIGHT
46
# OF OVERLAPPING
HOLDINGS
HEAL.L
197
HOLDINGS
31%
ALSO IN XDG3.DE
XDG3.DE
111
HOLDINGS
43%
ALSO IN HEAL.L
SECTOR DRIFT (HEAL.L minus XDG3.DE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HEAL.L |
Weight in XDG3.DE |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 2.2% | 4.8% | 2.2% |
 |
GSK PLC | 1.9% | 2.9% | 1.9% |
|
GILEAD SCIENCES INC | 1.9% | 4.3% | 1.9% |
|
BRISTOL-MYERS SQUIBB CO | 1.8% | 4.6% | 1.8% |
|
AMGEN INC | 1.8% | 4.6% | 1.8% |
HEAL.L Overweight Relative to XDG3.DE
|
ILLUMINA INC | 2.5% |
|
JOHNSON & JOHNSON | 2.3% |
 |
UCB SA | 2.3% |
|
BIOGEN IDEC INC | 2.2% |
|
NATERA INC | 2.0% |
 |
NOVARTIS AG | 1.9% |
 |
CELLTRION INC | 1.8% |
|
IQVIA HOLDINGS INC | 1.7% |
 |
BEIGENE, LTD. | 1.7% |
|
PFIZER INC | 1.7% |
HEAL.L Underweight Relative to XDG3.DE
|
ELI LILLY & CO | -5.0% |
 |
NOVO NORDISK A/S-B | -4.9% |
|
VERTEX PHARMACEUTICALS INC | -4.8% |
|
ASTRAZENECA PLC | -4.5% |
|
STRYKER CORP | -4.2% |
 |
SANOFI-AVENTIS | -3.0% |
|
ABBVIE INC | -2.9% |
|
AMGEN INC | -2.8% |
|
BRISTOL-MYERS SQUIBB CO | -2.8% |
|
REGENERON PHARMACEUTICALS | -2.7% |